Showing results (1-10 of 689) with videos related to
Sort By:
Pageof 69
The Journal of Clinical Investigation|February 16, 2026
The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medicationsRyan J Jalleh, Nicholas J Talley, Michael Horowitz, et al.The American Journal of Medicine|January 4, 2011
Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implicationsMichael A NauckThe American Journal of Medicine|May 26, 2009
Unraveling the science of incretin biologyMichael A NauckEuropean Journal of Internal Medicine|July 8, 2009
Unraveling the science of incretin biologyMichael A NauckDiabetes Care|May 7, 2013
A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risksMichael A NauckDrug Design, Development and Therapy|September 24, 2014
Update on developments with SGLT2 inhibitors in the management of type 2 diabetesMichael A NauckJournal of Diabetes Investigation|May 21, 2014
Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failureMichael A Nauck, Irfan VardarliThe Journal of Clinical Endocrinology and Metabolism|February 24, 2006
Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responsesTanya J Little, Amelia N Pilichiewicz, Antonietta Russo, et al.Diabetes, Obesity & Metabolism|January 25, 2018
Incretin hormones: Their role in health and diseaseMichael A Nauck, Juris J MeierDiabetologia|May 22, 2015
Incretin-based therapies: where will we be 50 years from now?Juris J Meier, Michael A NauckPageof 69